Trauma patients on new oral anticoagulation agents have lower mortality than those on warfarin

摘要

BACKGROUND Although anticoagulation with warfarin has been associated with increased risk of adverse outcomes after trauma, the effects of the new oral agents (NOA) such as dabigatran, apixaban, rivaroxaban are not yet well characterized.